Kiniksa Pharmaceuticals, Ltd.
Kiniksa Pharmaceuticals, Ltd.（KNSA）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
knsa · 股价预测 · 11 位分析师（近3月）· FMP · 更新于 2026年6月9日
分析师评级与共识
基于过去 3 个月内 11 位华尔街分析师
Buy
11 位分析师
共识
评级分布
12 个月目标价
High
$71.00
Consensus
$64.00
+30.5% upside
Low
$59.00
Median: $62 · Last Close: $49.04
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$64.00
30.5% upside
High Target
$71
44.8%
Low Target
$59
20.3%
Current Price
$49.04
as of today
Based on analyst price targets, the KNSA stock price prediction for the next 12 months ranges from $59 to $71. The consensus KNSA price forecast of $64.00 implies 30.5% upside from the current price of $49.04.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $46.59 | ↓ 5.00% |
1-day model range: $46.17–$47.01. Peak: $47.01 (-5.00%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $79 | +60.2% |
| 2028 | $107 | +118.2% |
| 2029 | $130 | +165.5% |
| 2030 | $147 | +200.0% |
| 2031 | — | +223.5% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · KNSA · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-04-29 | Wedbush | Maintains | Outperform→Outperform |
| 2026-04-29 | Canaccord Genuity | Maintains | Buy→Buy |
| 2026-04-29 | Wells Fargo | Maintains | Overweight→Overweight |
| 2026-04-29 | Citigroup | Maintains | Buy→Buy |
| 2026-04-28 | Jefferies | Maintains | Buy→Buy |
| 2026-04-16 | Wedbush | Maintains | Outperform→Outperform |
| 2026-02-25 | Wells Fargo | Maintains | Overweight→Overweight |
| 2026-02-25 | Wedbush | Maintains | Outperform→Outperform |
| 2026-01-13 | Wedbush | Maintains | Outperform→Outperform |
| 2025-10-29 | Goldman Sachs | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Kiniksa Pharmaceuticals, Ltd. (KNSA) stock. Of the recent 36 rating actions, 1 were upgrades and 0 were downgrades. 11 analysts currently cover KNSA.
分析师推荐趋势
KNSA analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 6 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$939M
↓ 25.9% YoY
Revenue Next Year
$1.1B
↑ 19.9% YoY
EPS This Year
$1.37
EPS Next Year
$1.91
↑ 39.6% YoY
EPS ForecastReported vs Estimated
Analysts forecast KNSA EPS of $1.37 for the current fiscal year, based on estimates from 4 analysts. The KNSA revenue forecast is $939M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
KNSA 股价预测由两类独立数据源支撑：来自 11 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。KNSA 的共识目标价为 $64.00（+30.5% 上行空间），分析师共识为 Buy。
KNSA 的短期预测（明日）为 $46.59（-5.00%）。 KNSA 对 2027 年的股价预测均值为 $79。 KNSA 对 2030 年的预测区间为 $133–$162。
Kiniksa Pharmaceuticals, Ltd. 在 NASDAQ 上市，代码 KNSA。KNSA 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。
常见问题
KNSA 预测 · 8 个问题根据 11 位华尔街分析师，KNSA 的 12 个月平均目标价为 $64.00，最高 $71.00、最低 $59.00。若有图表，中位目标价可在上方查看。相对当前价 $49.04，隐含约 +30.5% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.